Contribution: Industrial Research Assistance Program – Contributions to Firms
Braver inc.
$50,000.00
Generic integration module in a highly secure environment
FY 2021-22 · 2021-04-19
Summary
Braver aims to design an integrations module that will support highly secure interoperability paths with third-party partners, such as electronic patient record providers, at a lower cost.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
702432717
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-04-19 | 2021-22 | $50,000.00 |
| 1 | 2021-04-19 | 2021-22 | $50,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 62 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 62 jours.
Agreement End Date
2021-12-17
Agreement Number
970931
Agreement Start Date
2021-04-19
Agreement Title
Generic integration module in a highly secure environment
Agreement Title (French)
Module générique d'intégrations dans un contexte hautement sécurisé
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2021-09-27
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Braver aims to design an integrations module that will support highly secure interoperability paths with third-party partners, such as electronic patient record providers, at a lower cost.
Description (French)
Braver vise à concevoir un module d'intégrations qui permettra de supporter des voies d'intéropérabilité hautement sécurisées avec des partenaires tiers, tels que des fournisseurs de dossiers patients électroniques, et ce à moindre coût.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
541514
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
702432717
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Braver inc.
Recipient Operating Name
Braver
Recipient Postal Code
G1K 3A6
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2021-2022-Q1-970931
